Delivery Order SPE2DB22D1103-SPE2DB24FTKN3
Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $2.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,530,476 units of Tamsulosin HCl 0.4 mg capsules, a medication used to treat the symptoms of an enlarged prostate. The contract has a ceiling value of $6,483.58 and a completion date of May 8, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,976.30 fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat an enlarged prostate. The contract has an ultimate completion date of March 26, 2025. This award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $5,145.40 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat enlarged prostate. The contract has an ultimate completion date of May 16, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,439.63, is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract is a Firm Fixed Price Delivery Order with a completion date of November 14, 2024. This award is not designated as a set-aside contract. AmerisourceBergen holds a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,057.83, is for the supply of 1,000 capsules of Tamsulosin Hydrochloride 0.4 mg, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of July 19, 2024. This award is part of AmerisourceBergen's larger...
- This federal contract award, valued at $3,836.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,925,451 units of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a period of performance through March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Tamsulosin HCL 0.4 mg capsules, a medication used to treat enlarged prostate. The contract has a ceiling value of $1,904.28 and is a Firm Fixed Price Delivery Order with a completion date of May 15, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,914.22, is for the delivery of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat enlarged prostate. The award is a Delivery Order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 and...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract is valued at $3,433.57 and has a completion date of June 30, 2025. The contract is not designated as a set-aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,106.32 firm fixed-price delivery order is for the supply of 1,000 capsules of Tamsulosin HCl 0.4 mg, a medication used to treat an enlarged prostate. The contract has a completion date of June 11, 2024 and was awarded on June 10, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...